All posts by: Michael Zand

About Michael Zand

Scientists update guidelines for stem-cell research – The Globe and Mail (subscription)

Continue reading

2016-05-16 NEWS

The Globe and Mail (subscription)

Scientists update guidelines for stemcell research
The Globe and Mail (subscription)
“The public recognizes that stemcell research holds promise for treating diseases and disorders affecting millions of people around the world,” said Dr. George Daley, a professor of biological chemistry and molecular pharmacology at Harvard University
COLUMN: Georgia a stem cell leader? It’s the goal of state Sen. ThompsonNorthwest Georgia News
Scientists generate type of human stem cell that is ‘easier to edit’Jerusalem Post Israel News
Phyto Stem CellTheSequitur.com
Press Release Rocket
all 7 news articles »
Continue reading

2016-05-16 NEWS

Northwest Georgia News

COLUMN: Georgia a stem cell leader? It’s the goal of state Sen. Thompson
Northwest Georgia News
He is chairman of the Senate Science and Technology Committee and will serve on a Senate committee that will study issues concerning stem cell research and use. In particular, the group will delve into regulations, disciplinary action by regulatory
Scientists generate type of human stem cell that is ‘easier to edit’Jerusalem Post Israel News
Phyto Stem CellTheSequitur.com
Why Can’t We Experiment On Embryonic Stem Cells?Press Release Rocket

all 6 news articles »

Continue reading

2016-05-16 NEWS

Edison Issues Initiation on International Stem Cell
PR Newswire (press release)
International Stem Cell (ISCO) is an early-stage cell therapy company currently in Phase I/IIa clinical trials to treat Parkinson’s disease (PD). In addition, ISCO sells skincare and biomedical supplies to the market, generating $8m in sales and $1.7m

and more »

Continue reading

2016-05-16 NEWS

Broadening Scope of Stem Cell Research Propels Global Cell Expansion Market
Medgadget.com (blog)
Transparency Market Research is a top provider of the latest information on market activities. It comprises vast expanses of knowledge on multiple industry verticals, one of which is the global industry of biotechnology. “Cell Expansion Market – Global

and more »

Continue reading

2016-05-16 NEWS

Health Aim

Stem Cell Therapy Can Provide Autonomous Insulin Secretion, Solves Diabetes
Health Aim
Using Stem Cell Therapy, it is possible to provide autonomous insulin secretion into the blood stream. For those who suffer Type 1 Diabetes, insulin shots, blood sugar monitoring, and carb counting are part if daily routine – usually for the rest of
Stem cells from diabetic patients coaxed to become insulin-secreting cells(e) Science News (press release) (registration)

all 53 news articles »